Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -9.62x is 52% above its 4-year average of -20.11x, near the high end of its 4-year range (-88.57x–-0.66x).
As of the fiscal period ended Wednesday, March 31, 2021.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2021 (2021-03-31): -9.62x.
INTEREST COVERAGE RATIO
-9.62x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-11.90x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+19.17%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 361 covered companies
CURRENT VS SECTOR MEDIAN
-126.89%
vs the sector median at left
Krystal Biotech, Inc.
Market Cap
$9.48B
Interest Coverage Ratio
-9.62x
TTM Avg
N/A
3Y Avg
-11.90x
5Y Avg
N/A
Market Cap
$9.37B
Interest Coverage Ratio
5.94x
TTM Avg
6.59x
3Y Avg
5.07x
5Y Avg
3.90x
Market Cap
$9.34B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$9.72B
Interest Coverage Ratio
5.05x
TTM Avg
5.30x
3Y Avg
10.04x
5Y Avg
14.14x
Market Cap
$9.04B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$10.05B
Interest Coverage Ratio
53.24x
TTM Avg
48.24x
3Y Avg
40.33x
5Y Avg
37.20x
Market Cap
$10.08B
Interest Coverage Ratio
4.07x
TTM Avg
9.27x
3Y Avg
11.38x
5Y Avg
10.77x
Market Cap
$8.74B
Interest Coverage Ratio
-25.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.20B
Interest Coverage Ratio
5.52x
TTM Avg
5.51x
3Y Avg
7.63x
5Y Avg
62.06x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | $9.48B | -9.62x | N/A | -11.90x | N/A |
| Insulet Corp. (PODD)vs › | $9.37B | 5.94x | 6.59x | 5.07x | 3.90x |
| Bruker Corporation (BRKR)vs › | $9.34B | 3.91x | 4.60x | 15.68x | 18.14x |
| Henry Schein, Inc. (HSIC)vs › | $9.72B | 5.05x | 5.30x | 10.04x | 14.14x |
| Bruker Corporation (BRKRP)vs › | $9.04B | 3.91x | 4.60x | 15.68x | 18.14x |
| The Ensign Group, Inc. (ENSG)vs › | $10.05B | 53.24x | 48.24x | 40.33x | 37.20x |
| Molina Healthcare, Inc. (MOH)vs › | $10.08B | 4.07x | 9.27x | 11.38x | 10.77x |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.74B | -25.81x | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.20B | 5.52x | 5.51x | 7.63x | 62.06x |
| Align Technology, Inc. (ALGN)vs › | $10.23B | N/A | 67.41x | 66.08x | 407.22x |
Interest Coverage
-9.6x
Debt/Equity
0.01
Current Ratio
8.32
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-03-31 | -9.62x |
| 2018-12-31 | -4.11x |
| 2018-09-30 | -13.70x |
| 2018-06-30 | -14.16x |
| 2018-03-31 | -17.93x |
| 2017-09-30 | -0.66x |
| 2017-06-30 | -16.25x |
| 2017-03-31 | -16.03x |
| 2016-12-31 | -88.57x |
